Daratumumab for T Cell ALL With MRD-positive After Standard Chemotherapy
Clinical trial NCT06570915 · WITHDRAWN
Trial details
- NCT number
- NCT06570915
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2027-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.